📰 Stephen Hrusovsky News
Stephen Hrusovsky News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stephen Hrusovsky. Real-time updates on events, politics, business and more.
June 6, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
March 29, 2022
Funding will power a series of prospective clinical trials to validate Quanterix' multi-analyte test in collaboration with Amsterdam University Medical Centers (Amsterdam UMC) Quanterix Corporation
February 8, 2022
Leading academic lab harnesses Simoa digital biomarker analysis technology providing up to 1000x greater sensitivity than traditional immunoassays Powering Precision Health 2022 Alzheimer's podcast
February 19, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
February 13, 2021
Posted on 17276 Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agreement to open a joint Simoa laboratory with WuXi AppTec to improve access to Quanterix’ industry leading biomarker testing and development offerings across China and the APAC market. The Simoa® Joint Lab is the strategic partnership between the two comp...
February 12, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec February 12, 2021 GMT BILLERICA, Mass.--(BUSINESS WIRE)--Feb 12, 2021-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agreement to open a joint Simoa laboratory with WuXi AppTec to improve access to Quanterix’ industry leading...
January 23, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 17, 2021
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its Simoa SARS-CoV-2 N Protein Antigen Test that can be run on the Simoa HD-X Analyzer,...
January 13, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. Quanterix Provides Operational and Preliminary Financial Highlights January 13, 2021 GMT BILLERICA, Mass.--(BUSINESS WIRE)--Jan 13, 2021-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today provided operational and preliminary financial highlights for the fourth quarter and fiscal year ended December 31, 2020. “While last ye...